Free Trial

Cambridge Nutritional Sciences (CNSL) Competitors

GBX 3.10 +0.05 (+1.64%)
As of 04:16 AM Eastern

CNSL vs. CEL, OTT, FOX, BCE, CZN, CHT, DVW, BRCI, NPT, and RCI

Should you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Oxford Technology 3 Venture Capital Trust (OTT), Fox Marble (FOX), Beacon Energy (BCE), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry.

Cambridge Nutritional Sciences vs. Its Competitors

Celadon Pharmaceuticals (LON:CEL) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

In the previous week, Celadon Pharmaceuticals' average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
Celadon Pharmaceuticals Neutral
Cambridge Nutritional Sciences Neutral

Celadon Pharmaceuticals has a beta of -0.26, suggesting that its share price is 126% less volatile than the S&P 500. Comparatively, Cambridge Nutritional Sciences has a beta of 3.89, suggesting that its share price is 289% more volatile than the S&P 500.

Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98-1.68
Cambridge Nutritional Sciences£8.33M0.89-£3.03M£0.01442.86

10.7% of Celadon Pharmaceuticals shares are held by institutional investors. Comparatively, 2.8% of Cambridge Nutritional Sciences shares are held by institutional investors. 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Comparatively, 8.7% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cambridge Nutritional Sciences has a net margin of -3.36% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Celadon Pharmaceuticals-4,024.62% -187.26% -34.40%
Cambridge Nutritional Sciences -3.36%-3.34%-2.36%

Summary

Cambridge Nutritional Sciences beats Celadon Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

Get Cambridge Nutritional Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNSL vs. The Competition

MetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£7.38M£2.72B£5.66B£2.57B
Dividend YieldN/A2.04%5.75%5.32%
P/E Ratio442.86283.6576.225,390.72
Price / Sales0.8997.65559.2398,506.30
Price / CashN/A146.5437.6027.92
Price / Book0.782.3712.378.03
Net Income-£3.03M£99.80M£3.29B£5.89B
7 Day Performance3.16%-1.23%1.07%15.32%
1 Month Performance3.06%-1.13%3.59%2.69%
1 Year Performance-18.29%111.94%60.72%156.67%

Cambridge Nutritional Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.10
+1.6%
N/A-20.4%£7.38M£8.33M442.863,200
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780
OTT
Oxford Technology 3 Venture Capital Trust
N/AN/AN/AN/A£2.13M-£85K-12.59203Gap Down
FOX
Fox Marble
N/AGBX 0.05
flat
N/A-96.0%£1.13MN/A-132.5010,600High Trading Volume
BCE
Beacon Energy
N/AGBX 0
flat
N/AN/A£740KN/A-3.6444,600
CZN
Curzon Energy
N/AN/AN/AN/A£34KN/A-3.4014,700Gap Down
CHT
290005 (CHT.L)
N/AN/AN/AN/A£0.00N/A0.0020,300
DVW
5008 (DVW.L)
N/AN/AN/AN/A£0.00N/A0.00N/AGap Up
BRCI
BlackRock Comms Income Inv Tst
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
NPT
NetPlay TV
N/AN/AN/AN/A£0.00N/A0.00147,000
RCI
RapidCloud International
N/AN/AN/AN/A£0.00N/A0.0023,000

Related Companies and Tools


This page (LON:CNSL) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners